Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome
Open Access
- 8 July 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 23 (10), 2352-2358
- https://doi.org/10.1093/humrep/den263
Abstract
Polycystic ovary syndrome (PCOS) is associated with insulin resistance and features in common with the metabolic syndrome (MetS)—factors shown to predict cardiovascular risk and type 2 diabetes. We investigated the prevalence and characteristics of the MetS in PCOS by three definitions—World Health Organization (WHO), National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP-III) and International Diabetes Federation (IDF)—and compared that with the background population. Cross-sectional study of 168 women with PCOS and 883 age-matched controls from the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Prevalence of the MetS in PCOS subjects was 33% by WHO, 37% by NCEP-ATP-III and 40% by IDF criteria, compared with 10% by NCEP-ATP-III and 13% by IDF in controls (P < 0.001). MetS by WHO criteria was not calculated in the AusDiab population. Age was an independent predictor of MetS in PCOS and controls. The prevalence of MetS was significantly higher among those with PCOS (P = 0.027) in obese women (BMI > 30 kg/m2), and higher but not significantly so in overweight (BMI 25–30 kg/m2) women (P = 0.052). Dehydroepiandrosterone sulphate was associated with a lower risk of the MetS—Odds ratio 0.86 (95% confidence interval, 0.77–0.97, P = 0.011). An approximate 4-fold increase in the prevalence of the MetS in women with PCOS compared with the general population, consistent with the proposed major role of insulin and obesity in the syndrome, implies greater risk of cardiometabolic disease in women with PCOS. However, this estimate is likely to vary according to PCOS definition, ethnicity and different aetiological pathways to PCOS.Keywords
This publication has 29 references indexed in Scilit:
- The Metabolic Syndrome in Australia: Prevalence using four definitionsDiabetes Research and Clinical Practice, 2007
- Selecting controls is not selecting “normals”: Design and analysis issues for studying the etiology of polycystic ovary syndromeFertility and Sterility, 2006
- Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are PrematureJournal of Clinical Endocrinology & Metabolism, 2006
- Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOSActa Endocrinologica, 2006
- Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectivesAtherosclerosis, 2005
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2005
- Endogenous Androgens and Carotid Intimal-Medial Thickness in WomenJournal of Clinical Endocrinology & Metabolism, 1999
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998
- Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndromeClinical Endocrinology, 1992